CASI PHARMACEUTICALS, INC. Net Change in Cash
CASI PHARMACEUTICALS, INC. (CASIF) reported Net Change in Cash of -$7.84 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2026-05-15
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month |
|---|---|
| 2025-12-31 | -$7.84M 20-F · filed 2026-05-15 |
| 2024-12-31 | -$3.62M 20-F · filed 2026-05-15 |
| 2023-12-31 | -$30.03M 20-F · filed 2026-05-15 |
| 2022-12-31 | $8.41M 20-F · filed 2025-03-31 |
| 2021-12-31 | -$18.36M 20-F · filed 2024-03-28 |
| 2020-12-31 | $3.44M 20-F · filed 2023-04-26 |